Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Intravenous Sodium Thiosulfate for Acute Calciphylaxis Treatment: A Multicenter, Randomized, Double-blind, Placebo-controlled, Clinical Trial

NCT03150420 is registered in ClinicalTrials.gov with Hope Pharmaceuticals as lead sponsor.

NCT NCT03150420
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03150420 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Intravenous Sodium Thiosulfate for Acute Calciphylaxis Treatment: A Multicenter, Randomized, Double-blind, Placebo-controlled, Clinical Trial
Lead sponsor
Hope Pharmaceuticals
Phase
Phase 3
Overall status
Terminated
Start date
May 24, 2017
Completion date
April 15, 2020
Enrollment
29 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

calciphylaxis